Inventor · disambiguated record
Rachel Caspi
Also filed as: CASPI RACHEL · CASPI RACHEL R
3 granted patents·6 pending applications·68 citations·filing 1987–2019
67Inventor score
Files withUS GOV HEALTH & HUMAN SERV2CUA DANIEL J1GOVERNMENT OF THE US SECRETARY OF THE DEP OF H H S1MERCK SHARP & DOHME1SCHERING CORP1
Top patents by PatentIndex Score
9 records- 0170US8524230B2Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory diseaseCUA DANIEL J·Filed 2009·Granted Sep 3, 2013·2 cites·1 claims
- 0267US5422270AOne-step tray test for release of soluble mediators and apparatus thereforeUS ARMY·Filed 1987·Granted Jun 6, 1995·66 cites·6 claims
- 0358US2014248279A1Use of il-23 and il-17 antiagonists to treat autoimmune ocular inflammatory diseaseMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 0455US2008199460A1Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory diseaseUS GOV HEALTH & HUMAN SERV·Filed 2006·Application pending·0 cites
- 0554US2013323251A1Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory diseaseGOVERNMENT OF THE US SECRETARY OF THE DEP OF H H S·Filed 2013·Application pending·0 cites
- 0651US2011142831A1Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory diseaseSCHERING CORP·Filed 2011·Application pending·0 cites
- 0738US10512671B2IL-24 to treat inflammatory diseasesUS HEALTH·Filed 2018·Granted Dec 24, 2019·0 cites·24 claims
- 0835US2013045943A1A3ar agonists for the treatment of uveitisUS GOV HEALTH & HUMAN SERV·Filed 2011·Application pending·0 cites
- 0932US2021009651A1Use of il-34 to treat retinal inflammation and neurodegenerationTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SE·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rachel Caspi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →